Form 4 for BIIB Biogen
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001127602-24-014199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-03 | 2024-05-01 | BIIB | Keeney Adam | Head of Corp. Development | M - OptEx | $0.00 | +938 | 938 | New | $0 |
| D | 2024-05-03 | 2024-05-01 | BIIB | Keeney Adam | Head of Corp. Development | F - Tax | $216.13 | -276 | 662 | -29% | -$59.7K |
| D | 2024-05-03 | 2024-05-01 | BIIB | Keeney Adam | Head of Corp. Development | M - OptEx | $0.00 | -938 | 1,877 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | M | A | 938 | $0.00 | 938 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-01 | F | D | 276 | $216.13 | 662 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-05-01 | M | D | 938 | $0.00 | 1,877 | D | $0.00 · — to 2026-05-01 | 938 Common Stock | (F1) The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of May 1, 2023. |